Zobrazeno 1 - 10
of 468
pro vyhledávání: '"Focal glomerulosclerosis"'
Autor:
Ahmed A. Abo Elnaga, Mohamed A. Alsaied, Abdelrahman M. Elettreby, Alaa Ramadan, Mohamed Abouzid, Raghda Shetta, Yazan A. Al-Ajlouni
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Sparsentan has shown positive effects on managing different subtypes of glomerulonephritis. The recent results of trials require a pooled analysis to validate these results. Aim We aim to assess the safety and efficacy of sparsent
Externí odkaz:
https://doaj.org/article/6b443702776f4154a5a2dc579fbf8135
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Érico Murilo Monteiro Cutrim, Precil Diego Miranda de Meneses Neves, Marcos Adriano Garcia Campos, Davi Campos Wanderley, Antonio Augusto Lima Teixeira-Júnior, Monique Pereira Rêgo Muniz, Francisco Rasiah Ladchumananandasivam, Orlando Vieira Gomes, Rafael Fernandes Vanderlei Vasco, Dyego José de Araújo Brito, Joyce Santos Lages, Natalino Salgado-Filho, Felipe Leite Guedes, José Bruno de Almeida, Marcelo Magalhães, Stanley de Almeida Araújo, Gyl Eanes Barros Silva
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Collapsing glomerulopathy (CG) is a clinicopathologic entity characterized by segmentar or global collapse of the glomerulus and hypertrophy and hyperplasia of podocytes. The Columbia classification of 2004 classified CG as a histological subtype of
Externí odkaz:
https://doaj.org/article/591d23eaf936462ead33c874faaa415c
Publikováno v:
Journal of Nephropathology, Vol 4, Iss 2, Pp 54-58 (2015)
Background: The natural evolution of C1q nephropathy (C1qNP) during immunosuppressive treatment is relatively little studied or understood. Case Presentation: A 30 year-old Caucasian female was referred to us for further management of biopsy-proven C
Externí odkaz:
https://doaj.org/article/1a86741c96ea46489719d6c28c5005f5
Publikováno v:
Kidney Research and Clinical Practice, Vol 31, Iss 4, Pp 205-213 (2012)
Circulating permeability factors have been identified in the plasma of patients with focal segmental glomerulosclerosis (FSGS). Post-transplant recurrence of proteinuria, improvement of proteinuria after treatment with plasmapheresis, and induction o
Externí odkaz:
https://doaj.org/article/b44554d6a1cf4d3e8746be370f328100
Autor:
E.K. Petrosyan, A.V. Ryzhova
Publikováno v:
Pediatria. Journal named after G.N. Speransky. 99:164-168
Autor:
Dino Kasumović, Petar Šenjug, Marko Lucijanic, Danica Galešić Ljubanović, Marko Pražetina, Matija Horaček, Nikola Zagorec, Ivica Horvatić, Krešimir Galešić
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims After membranous nephropathy, focal segmental glomerulosclerosis (FSGS) is the most common cause of nephrotic syndrome in European population. According to Columbia classification, there are five histological variants of FSGS defi
Autor:
Marta Arazzi, Eleonora Cristini, Simone Accarino, Giuseppe Sileno, Ettore Pasquinucci, Vittoria Esposito, Ciro Esposito, Marco Colucci
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Generalized edema, non responsive to oral diuretics, is one of the main causes of hospital admission for nephrotic syndrome patients. Although hospital length of stay (LOS) may vary widely, in 2017 the average LOS in acute-care ho
Autor:
Nihad Tamimi, Daniel Levy, Jose Alvir, Christine L. Baker, Stephen P. Berasi, Suneel M. Udani, Kam Kalantar-Zadeh, J. Brian Copley
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims The burden of disease associated with FSGS has not been well characterized, especially with regard to health care resource utilization (HCRU) and related costs. The aim of this study was to evaluate all-cause HCRU and estimate ass
Autor:
José María Peña Porta, Ana Coscojuela Otto, Almudena Castellano Calvo, José Antonio Ferreras Gascó, Rafael Álvarez Lipe, Paula Juarez Mayor
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Lipid disorders are a characteristic manifestation that accompanies the presentation of nephrotic syndrome (NS). The pathophysiology underlying its origin is debated in the literature. It is important to collect large series of pa